Morning, Thursday, 7th March 2019
THIS EVENT IS CPD CERTIFIED
Bringing together stakeholders and policymakers, this conference will discuss key issues in pharmaceutical pricing, access to medicines and priorities for implementing the next instalment of the Pharmaceutical Price Regulation Scheme
With the 2014 Pharmaceutical Price Regulation Scheme set to expire on the 31st of December 2018, and discussions ongoing about the potential shape and structure of any successor agreement, delegates will consider the potential impact of the next instalment on the NHS, industry and access to medicine.
Attendees will also assess what options are available to policymakers as they look to support medicine optimisation and reduce expenditure on medicines - with the Department of Health and Social Care analysing feedback from their consultation on proposed changes to the statutory scheme to control the cost of branded medicines, which seeks guidance on whether to include biologics in price controls.
Discussion is also planned on the challenges of bringing new products to the market - which will include the impact of the Accelerated Access Collaborative designed to support the breakthrough of new medicine and technology, proposals to allow NICE to charge companies for technology appraisals, and what more can be done to support the industry to develop the skills and expertise needed to develop new and innovative medicines.